Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study of Light Therapy and Melatonin for Treatment of Major Depressive Episode with Insomnia
FranceStudy of cilostazol and nimodipine combination to improve outcomes in patients with aneurysmal subarachnoid hemorrhage
FranceStudy of clopidogrel and acetylsalicylic acid (aspirin) for prevention of cardiovascular events in patients who survived intracerebral hemorrhage stroke
BelgiumStudy of TAK-360 tablets to evaluate safety and effectiveness in people with Idiopathic Hypersomnia
FranceStudy of levetiracetam to prevent seizures in adults who have both Down syndrome and Alzheimer's disease
SpainStudy on Amlodipine for Treating Reversible Cerebral Vasoconstriction Syndrome in Patients Without Brain Lesions or Hemorrhage
FinlandStudy on Long-term Safety and Efficacy of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
BelgiumLong-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2
BelgiumStudy on Botulinum Toxin A for Tinnitus in Patients with Bruxism or Jaw Muscle Pain
NorwayStudy of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment
BelgiumStudy on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis
FranceStudy on the Effects of ILB and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)
NorwayThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
